Navigation Links
The Pulmonary Hypertension Association and MedicAlert Foundation Form Alliance to Safeguard Patients

SILVER SPRING, Md., July 28, 2011 /PRNewswire-USNewswire/ -- Furthering their efforts to provide support to pulmonary hypertension (PH) patients, the Pulmonary Hypertension Association (PHA) has entered into a partnership with MedicAlert Foundation that will offer PHA members a discount on MedicAlert membership. By joining MedicAlert, PHA members will benefit from MedicAlert's unique, live 24/7 emergency response/family notification services should an emergency arise. Additionally, PHA members who join MedicAlert will have the ability to store and manage an online Emergency Medical Information Record (EMIR), which allows them to maintain updated health information, medications, test results, and physician contacts. The MedicAlert EMIR has been designed in conjunction with the American College of Emergency Physicians to contain the critical information needed by first responders and hospital emergency departments. MedicAlert membership provides medical and emergency response staff with swift access to patients' key health information, enabling them to quickly recognize patients with pulmonary hypertension and administer proper treatment.

"PH is a life-threatening illness in which the vessels in the lungs thicken and constrict, leading to heart failure," says Rino Aldrighetti, President and CEO of the Pulmonary Hypertension Association. "Because the disease is not commonly seen by most medical professionals, a MedicAlert medical ID can lead to quick understanding and appropriate response in an emergency situation."

Pulmonary hypertension treatments are complex and difficult. In some cases, standard emergency medical procedures may be life-threatening to PH patients. Proactive education of emergency responders and medical staff, coupled with MedicAlert's live 24/7 identification and information services, helps to ensure that PH patients will receive the care they need in an emergency situation.

"We are proud to be working alongside the Pulmonary Hypertension Association in the effort to educate and advocate on behalf of the pulmonary hypertension community," said Andrew B. Wigglesworth, President & CEO of MedicAlert Foundation. "MedicAlert services provide critical support for individuals with complex illnesses like PH by relaying vital medical information in an emergency. Our proven capability to speak on behalf of our members during medical emergencies has positioned MedicAlert as the leading communication service for the PH patient community."

For more information about the Pulmonary Hypertension Association and MedicAlert Foundation's special offer, visit  

About MedicAlert Foundation

Established in 1956, MedicAlert Foundation pioneered the use of medical IDs and systems to relay vital medical information to emergency responders on behalf of its members so they receive faster and safer treatment. Today, MedicAlert provides the functionality of an e-health information exchange through an innovative combination of a unique patient identifier linked to an emergency medical information record and a live 24/7 emergency response service. MedicAlert medical IDs alert emergency personnel to a member's primary health conditions, medications, and/or implanted medical devices. In addition to its live 24/7 emergency response service, MedicAlert Foundation also provides family and caregiver notification so that members can be reunited with their loved ones. MedicAlert services are available around the world through a network of international nonprofit affiliated organizations licensed by the Foundation. Learn more at

About The Pulmonary Hypertension Association (PHA)

Headquartered in Silver Spring, Maryland, PHA is the country's leading organization connecting pulmonary hypertension patients, families, and medical professionals. Its mission is to find ways to prevent and cure pulmonary hypertension and provide hope for the community through support, education, advocacy, and awareness. PHA provides free access to information on its website about pulmonary hypertension and facilitates over 200 support groups around the nation, helping many of the estimated 30,000 diagnosed patients in the United States. To learn more, visit

SOURCE MedicAlert Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
2. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
3. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
4. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
5. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
8. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
9. APTA Supports Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
10. Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
11. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
Post Your Comments:
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
(Date:6/23/2016)... PRINCETON, N.J. , June 23, 2016  Guerbet ... of Premier Inc.,s Supplier Horizon Award . ... this year, Guerbet was recognized for its support of ... value creation through clinical excellence, and commitment to lower ... delighted to receive this recognition of our outstanding customer ...
(Date:6/23/2016)... 2016 The Biotechnology industry might ... present great opportunities to investors. assesses the recent ... (NYSE: XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... receive your complimentary trade alerts at: ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):